RT Journal Article
SR Electronic
T1 Modelling the population-level protection conferred by COVID-19 vaccination
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.16.21253742
DO 10.1101/2021.03.16.21253742
A1 Padmanabhan, Pranesh
A1 Desikan, Rajat
A1 Dixit, Narendra M.
YR 2021
UL http://medrxiv.org/content/early/2021/03/20/2021.03.16.21253742.abstract
AB Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines work predominantly by eliciting neutralizing antibodies (NAbs), how the protection they confer depends on the NAb response to vaccination is unclear. Here, we collated and analysed in vitro dose-response curves of >70 NAbs and constructed a landscape defining the spectrum of neutralization efficiencies of NAbs elicited. We mimicked responses of individuals by sampling NAb subsets of known sizes from the landscape and found that they recapitulated responses of convalescent patients. Combining individual responses with a mathematical model of within-host SARS-CoV-2 infection post-vaccination, we predicted how the population-level protection conferred would increase with the NAb response to vaccination. Our predictions captured the outcomes of vaccination trials. Our formalism may help optimize vaccination protocols, given limited vaccine availability.One sentence summary Viremic control by the spectrum of neutralizing antibodies elicited by vaccination determines COVID-19 vaccine efficacies.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialOurs is a computational study and did not involve conducting trials.Funding StatementThis work was supported by the DBT/Wellcome Trust India Alliance Senior Fellowship IA/S/14/1/501307 to NMD.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No approvals were required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available within the submission.